Virtual Reality Versus Constraint-induced Movement on Hemiparesis in Cerebrovascular Event

Launched by COORDINACIÓN DE INVESTIGACIÓN EN SALUD, MEXICO · May 16, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how two different rehabilitation methods—Virtual Reality therapy and Modified Constraint-Induced Movement Therapy—can help improve movement in patients who have weakness on one side of their body after a stroke. The goal is to see if these new therapy options are more effective than standard physical and occupational therapy in helping patients regain function in their affected limbs.

To participate in the study, you need to be an adult between 35 and 70 years old who has had a stroke affecting the middle part of the brain, resulting in weakness on one side of your body. You should be recovering from your stroke for about 1 to 3 months and be able to agree to join the study, either by yourself or with the help of a family member. If you join, you’ll engage in either virtual reality exercises or specific movement-restriction activities, and researchers will monitor your progress, as well as how satisfied you feel with the treatment. It's important to note that you cannot have any serious cognitive issues or experience another stroke during the study. This trial could provide valuable information on how to better support recovery for stroke patients like you.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients between 35 and 70 years of age and with a clinically and tomographically proven diagnosis of a cerebral vascular event in the territory of the middle cerebral artery.
• • Patients with hemiparesis secondary to the cerebrovascular event
• • Patients with a maximum Ashworth of 2 and Brunnstrom of minimum 4
• • Patients with or without aphasia
• • Patients with evolution between 1 to 3 months from hospital discharge of the cerebrovascular event
• • Patients with cerebrovascular event of any sex
• • Patients with vascular event without cognitive deficit
• • Patients who agree to participate by signing an informed consent, by them or their family member or person in charge.
• Exclusion Criteria:
• • Patients who develop dementia or neurological-psychomotor complications during the study.
• • Patients who present a new cerebrovascular event during the investigation
• • Patients who do not complete at least 90% of the program
• • Patients in whom a lack of family support or secondary gain is detected.